Literature DB >> 25225052

ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids.

Chunyong Ding1, Lili Wang, Haijun Chen, Christopher Wild, Na Ye, Ye Ding, Tianzhi Wang, Mark A White, Qiang Shen, Jia Zhou.   

Abstract

A mild and concise approach for the construction of a 3,4-dihydro-2H-pyran ring integrated into the A-ring of the natural product oridonin using an optimized inverse electron demand hetero-Diels-Alder (IED HDA) reaction is reported herein. A self-dimerization of the exocyclic enone installed in the A-ring through a homo-HDA reaction was identified to exclusively give a dimeric ent-kaurane diterpenoid with the spirochroman core. Moreover, efficient cross-HDA cycloadditions of this enone with various vinyl ethers or vinyl sulfides, instead of its own homo-HDA dimerization, were achieved in a regio- and stereoselective manner, thus providing access to novel dihydropyran-fused diterpenoids as potential anticancer agents to overcome chemoresistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25225052      PMCID: PMC4192081          DOI: 10.1039/c4ob01040j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  47 in total

1.  Total synthesis of (+)-phorboxazole A.

Authors:  A B Smith; P R Verhoest; K P Minbiole; M Schelhaas
Journal:  J Am Chem Soc       Date:  2001-05-23       Impact factor: 15.419

2.  Revisiting the Maitland-Japp reaction. Concise construction of highly functionalised tetrahydropyran-4-ones.

Authors:  Paul A Clarke; William H C Martin; Jason M Hargreaves; Claire Wilson; Alexander J Blake
Journal:  Chem Commun (Camb)       Date:  2005-01-06       Impact factor: 6.222

3.  Racemization in Prins cyclization reactions.

Authors:  Ramesh Jasti; Scott D Rychnovsky
Journal:  J Am Chem Soc       Date:  2006-10-18       Impact factor: 15.419

4.  Highly Enantio- and Diastereoselective Hetero-Diels-Alder Reactions Catalyzed by New Chiral Tridentate Chromium(III) Catalysts.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  1999-08       Impact factor: 15.336

5.  A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma.

Authors:  Jaffer A Ajani; Yixing Jiang; Josephine Faust; Baochong B Chang; Linus Ho; James C Yao; Steven Rousey; Shaker Dakhil; Richard C Cherny; Catherine Craig; Archie Bleyer
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

6.  An anti-inflammatory ent-kaurane from the stems of Annona squamosa that inhibits various human neutrophil functions.

Authors:  Shang-Hsin Yeh; Fang-Rong Chang; Yang-Chang Wu; Yu-Liang Yang; Shi-Kai Zhuo; Tsong-Long Hwang
Journal:  Planta Med       Date:  2005-10       Impact factor: 3.352

7.  Novel nitrogen-enriched oridonin analogues with thiazole-fused A-ring: protecting group-free synthesis, enhanced anticancer profile, and improved aqueous solubility.

Authors:  Chunyong Ding; Yusong Zhang; Haijun Chen; Zhengduo Yang; Christopher Wild; Lili Chu; Huiling Liu; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2013-06-19       Impact factor: 7.446

Review 8.  Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics.

Authors:  Chun-yang Li; En-qin Wang; Yan Cheng; Jin-ku Bao
Journal:  Int J Biochem Cell Biol       Date:  2011-02-02       Impact factor: 5.085

9.  Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line.

Authors:  Hong-zhen Hu; Yue-bo Yang; Xiang-dong Xu; Hong-wei Shen; Yi-min Shu; Zi Ren; Xiao-mao Li; Hui-ming Shen; Hai-tao Zeng
Journal:  Acta Pharmacol Sin       Date:  2007-11       Impact factor: 6.150

10.  Bisrubescensins A-C: three new dimeric ent-kauranoids isolated from isodon rubescens.

Authors:  Sheng-Xiong Huang; Wei-Lie Xiao; Li-Mei Li; Sheng-Hong Li; Yan Zhou; Li-Sheng Ding; Li-Guang Lou; Han-Dong Sun
Journal:  Org Lett       Date:  2006-03-16       Impact factor: 6.005

View more
  13 in total

1.  Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads.

Authors:  Ye Ding; Dengfeng Li; Chunyong Ding; Pingyuan Wang; Zhiqing Liu; Eric A Wold; Na Ye; Haiying Chen; Mark A White; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2018-03-20       Impact factor: 7.446

Review 2.  Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.

Authors:  Haijun Chen; Yu Gao; Ailan Wang; Xiaobin Zhou; Yunquan Zheng; Jia Zhou
Journal:  Eur J Med Chem       Date:  2015-01-16       Impact factor: 6.514

Review 3.  Discovery and development of natural product oridonin-inspired anticancer agents.

Authors:  Ye Ding; Chunyong Ding; Na Ye; Zhiqing Liu; Eric A Wold; Haiying Chen; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  Eur J Med Chem       Date:  2016-06-13       Impact factor: 6.514

4.  Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.

Authors:  Fredrick J Bohanon; Xiaofu Wang; Brittany M Graham; Chunyong Ding; Ye Ding; Geetha L Radhakrishnan; Cristiana Rastellini; Jia Zhou; Ravi S Radhakrishnan
Journal:  J Surg Res       Date:  2015-08-05       Impact factor: 2.192

5.  Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells.

Authors:  Fredrick J Bohanon; Xiaofu Wang; Brittany M Graham; Anesh Prasai; Sadhashiva J Vasudevan; Chunyong Ding; Ye Ding; Geetha L Radhakrishnan; Cristiana Rastellini; Jia Zhou; Ravi S Radhakrishnan
Journal:  Mol Cell Biochem       Date:  2015-09-07       Impact factor: 3.396

6.  Effect of natural and semisynthetic pseudoguianolides on the stability of NF-κB:DNA complex studied by agarose gel electrophoresis.

Authors:  Rodrigo Villagomez; Rajni Hatti-Kaul; Olov Sterner; Giovanna Almanza; Javier A Linares-Pastén
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

7.  Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues.

Authors:  Wei Chen; Jiancheng Zhou; Kaijie Wu; Jun Huang; Ye Ding; Eun-Jin Yun; Bin Wang; Chunyong Ding; Elizabeth Hernandez; John Santoyo; Haiying Chen; Ho Lin; Arthur Sagalowsky; Dalin He; Jia Zhou; Jer-Tsong Hsieh
Journal:  Oncotarget       Date:  2016-08-30

8.  Design and synthesis of novel oridonin analogues as potent anticancer agents.

Authors:  Qing-Kun Shen; Zheng-Ai Chen; Hong-Jian Zhang; Jia-Li Li; Chuan-Feng Liu; Guo-Hua Gong; Zhe-Shan Quan
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 9.  Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance.

Authors:  Xi Liu; Jimin Xu; Jia Zhou; Qiang Shen
Journal:  Genes Dis       Date:  2020-07-05

Review 10.  Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound.

Authors:  Dahong Li; Tong Han; Jie Liao; Xu Hu; Shengtao Xu; Kangtao Tian; Xiaoke Gu; Keguang Cheng; Zhanlin Li; Huiming Hua; Jinyi Xu
Journal:  Int J Mol Sci       Date:  2016-08-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.